Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Guelph

$25,000.00

Biomaterial composites using glycogen nanoparticles for dermal applications

EF 2015-16

Résumé
PhytospherixTM is a naturally occurring phyto-glycogen nanoparticles extracted from corn by Mirexus Biotechnologies Inc. Unlike typical synthetic nanoparticles that are expensive and potentially toxic, PhytospherixTM nanoparticles are cost-effective, safe, non-toxic, and edible. These nanoparticles are extremely hydrophilic, capable of holding a larger quantity of water for longer time than hyaluronic acid - the gold standard for skin moisturizing formulation. They can be modified for the encapsulation of antioxidant and antimicrobial, making these nanoparticles an ideal material for delivering bioactives into the skin, for promoting skin health and wound healing. In spite of these desirable properties, Mirexus is currently facing challenges in developing free-standing nanocomposite membranes that possess optimal mechanical properties for skin and cosmetic and applications. Moreover, the company is also interested in developing methodologies to manipulate the barrier properties of these membranes, which is critical to achieve the optimal release rate of the PhytospherixTM nanoparticles and other bioactives. In order to expand this core product to high-value applications, Mirexus must overcome these manufacturing challenges. The company is seeking assistance from the PI to resolve these issues through the support of the Engage grant.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
477741-2015
Name nom
Lim, LoongTak
Department département
Food Science
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1208
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Materials sciences
Area of application fr
Sciences des matériaux
Research subject code
2006
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Biomaterials
Research subject fr
Biomatériaux
Partie
1
Nb partie
1
Application title
Biomaterial composites using glycogen nanoparticles for dermal applications
Keyword
NSERC
Application summary
PhytospherixTM is a naturally occurring phyto-glycogen nanoparticles extracted from corn by Mirexus Biotechnologies Inc. Unlike typical synthetic nanoparticles that are expensive and potentially toxic, PhytospherixTM nanoparticles are cost-effective, safe, non-toxic, and edible. These nanoparticles are extremely hydrophilic, capable of holding a larger quantity of water for longer time than hyaluronic acid - the gold standard for skin moisturizing formulation. They can be modified for the encapsulation of antioxidant and antimicrobial, making these nanoparticles an ideal material for delivering bioactives into the skin, for promoting skin health and wound healing. In spite of these desirable properties, Mirexus is currently facing challenges in developing free-standing nanocomposite membranes that possess optimal mechanical properties for skin and cosmetic and applications. Moreover, the company is also interested in developing methodologies to manipulate the barrier properties of these membranes, which is critical to achieve the optimal release rate of the PhytospherixTM nanoparticles and other bioactives. In order to expand this core product to high-value applications, Mirexus must overcome these manufacturing challenges. The company is seeking assistance from the PI to resolve these issues through the support of the Engage grant.